Virtual Breakfast Briefing: Shaping the UK’s position in the international community- innovation and regulatory perspectives 6 Oct 2021
PharmaMedic is delighted to announce our next event on Thursday 28th October 2021 at 8 am. As the UK life sciences sector continues its journey outside the EU, it’s time to forge a new role in the international community. This briefing will highlight some of the critical considerations we face from both innovation and regulatory perspectives.
Our agenda will incorporate two presentations, followed by a Q&A.
The first presentation by Hassan Chaudhury of Healthcare UK will review the UK’s evolving position on the global innovation stage and address how we can leverage our strengths for the future. Dr Zubair Hussain will then walk us through the current status of Project Orbis, a regulatory programme coordinated by the US Food and Drug Administration (FDA). Project Orbis allows participating partners, including the UK, to review and approve applications for promising cancer treatments more quickly.
08:00 – 08:10 – Welcome and Introductions Dr Malcolm Barratt-Johnson
08:10 – 08:25 –Is the UK still on the cutting edge of innovation? Hassan Chaudhury
08:25 – 08:40 –The role of Project Orbis Dr Zubair Hussain
08:40 – 08:55 – Q&A session Dr Malcolm Barratt-Johnson
Key discussion points will include:
- Is the UK still on the cutting edge of innovation?
- How can the UK life sciences community bring its strengths together to shape a new position in the global market?
- What is Project Orbis, and how can we learn from early experiences?
- What does the future hold for Project Orbis in terms of communication between the MHRA and the FDA?
The breakfast briefings are designed to offer an easily accessible format for busy pharmaceutical professionals and will conclude before your 9 am meetings.
Register here to attend, and feel free to forward the details to your colleagues.
About the speakers
Hassan Chaudhury promotes the UK Digital Health sector abroad at Healthcare UK; a joint initiative of the Department of Health and Social Care, NHS England and the Department for International Trade (DIT), with a global role advising commercial teams in over 100 UK embassies. His background is in frontline social work, NHS informatics, commissioning and public health. He was later a founder and Chief Commercial Officer of an award-winning real-world evidence (RWE) and health analytics agency until its acquisition and his exit in 2019.
He is a Director at Vita Healthcare, part of the commercial team at Great Ormond Street Hospital for Children, a member of the HIMSS Innovation Committee, the PM Society and The Institution of Engineering and Technology (IET) Healthcare Sector Exec Committee. He holds an Honorary Research post at Imperial College London for his work in data science.
Dr Zubair Hussain
Dr Zubair Hussain has over 25 years of experience in Regulatory Affairs, Quality Assurance and Compliance. His experience includes senior positions in small and large pharmaceutical and medical device companies, with global responsibilities for the EU, US, China, Russia, Asia and Latin America. His most recent corporate role was at Ipsen Biopharma, where Zubair held a global position as Senior Vice President, Global Head of Regulatory Affairs.
Zubair has also previously held the position of President for the TOPRA board, the trade association for professionals in regulatory affairs. Since 2016, Zubair has been chairman of LE4D Global Regulatory Science, providing innovative regulatory and clinical strategies to the healthcare industry. For further information – https://www.le4d.co.uk/
About the moderator:
Dr Malcolm Barratt-Johnson
Malcolm is the Managing Director of PharmaMedic and its Senior Consultant. He has over 18 years of experience as a UK / European based Consultant Pharmaceutical Physician to Industry and Government, specialising in Medical Affairs, Product Development and Regulatory Strategy.